{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:12:40Z","timestamp":1788912760202,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jneuroim.2011.11.010","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T23:44:08Z","timestamp":1323992648000},"page":"52-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse"],"prefix":"10.1016","volume":"243","author":[{"given":"Honghao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.11.010_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0167-5699(92)90138-W","article-title":"The two-signal model of lymphocyte activation twenty-one years later","volume":"13","author":"Bretscher","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micpath.2011.06.003","article-title":"Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B","author":"Cao","year":"2011","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1191\/1352458504ms1094oa","article-title":"IFN-beta treatment modulates the CD28\/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis","volume":"10","author":"Espejo","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2010.10.012","article-title":"Neuromyelitis optica: concepts in evolution","volume":"231","author":"Fazio","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2011.11.010_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1755-8794-2-46","article-title":"Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells","volume":"22","author":"Gurevich","year":"2009","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.jneuroim.2011.11.010_bb1000","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.410180407","article-title":"Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis","volume":"18","author":"Hafler","year":"1985","journal-title":"Ann Neurol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2249.2004.02427.x","article-title":"Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sj\u00f6gren's syndrome and systemic sclerosis","volume":"136","author":"Hebbar","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood\u2013brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ppul.20432","article-title":"Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children","volume":"41","author":"Ip","year":"2006","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2007.01.007","article-title":"Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis","volume":"185","author":"Kakoulidou","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2011.11.010_bb0055","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood\u2013brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0060","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction frommultiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jneuroim.2005.06.002","article-title":"Lack of association with the CD28\/CTLA4\/ICOS gene region among Norwegian multiple sclerosis patients","volume":"166","author":"Lorentzen","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0070","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y","article-title":"A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells","volume":"29","author":"Magistrelli","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0075","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1309\/AJCP7UBK8IBVMVNR","article-title":"Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay","volume":"136","author":"Martins","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0080","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ni1124","article-title":"CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86","volume":"5","author":"Orabona","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2008.00639.x","article-title":"CTLA-4: a key regulatory point in the control of autoimmune disease","volume":"223","author":"Scalapino","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0100","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jocn.2011.01.031","article-title":"Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse","volume":"18","author":"Wang","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-5728(03)00172-3","article-title":"The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1\/2 and regulational expression in multiple sclerosis","volume":"140","author":"Wiendl","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","article-title":"Neuromyelitis optica","volume":"10","author":"Wingerchuk","year":"2008","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2011.11.010_bb1005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.11.010_bb0120","doi-asserted-by":"crossref","first-page":"989-494","DOI":"10.1093\/rheumatology\/keh663","article-title":"Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus","volume":"44","author":"Wong","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2011.11.010_bb1010","first-page":"112","article-title":"T cell vaccination in multiple sclerosis: hopes and facts","volume":"94","author":"Zhang","year":"1994","journal-title":"Acta Neurol. Belg."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281100333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281100333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:17:47Z","timestamp":1759047467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281100333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S016557281100333X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.11.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2011 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}